Is Adjuvant Immunotherapy Worth for All Patients with Clear-cell Renal Cell Carcinoma at High Risk of Recurrence?

Thumbnail
Fulltext:
287565.pdf
Size:
1.039Mb
Format:
PDF
Description:
Publisher’s version
Download
Publication year
2022
Author(s)
Marchioni, M.
Amparore, D.
Marandino, L.
Bertolo, R.
Erdem, S.
Ingels, A.
Muselaers, S.
Kara, O.
Pavan, N.
Roussel, E.
Carbonara, U.
Pecoraro, Angela
Diana, P.
Pecoraro, Alessio
Campi, R.
Source
European Urology Open Science, 46, (2022), pp. 39-42
ISSN
DOI
Publication type
Article / Letter to editor
If a DOI or any other persistent identifier is unavailable, please use the following repository identifier to link to this item: https://hdl.handle.net/2066/287565   https://hdl.handle.net/2066/287565
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.